COVID-19 outbreak

Latest updates on the coronavirus and heart disease

Find out more

Our 25by25 Objective

Striving for a 25% reduction in premature mortality
caused by cardiovascular disease by 2025

Home > Global Advocacy > Our 25by25 Objective

In 2012, the World Heart Federation launched our 25by25 goal

The ’25 by 25′ campaign is in line with existing World Health Organization (WHO) commitments to reduce overall mortality from the four major non-communicable diseases (NCDs) – cardiovascular disease (CVD), including heart disease and stroke), diabetes, cancers and lung diseases – by 25% by 2025.

To support the broad 25by25 vision for NCDs, the WHO launched a set of targets and indicators in 2014. Achieving these targets, which are found in the Global Monitoring Framework, will have a direct impact on reducing the global burden of CVD.


per year die from CVD
per year die from cancers
per year die from CRDs
per year die from diabetes

Why 25by25

CVD accounts for 31% of global deaths: this amounts to 17.5 million people losing their lives every year. Over three quarters of CVD deaths take place in low- and middle-income countries, which carry heavy socio-economic burdens associated with CVD.

Beyond these alarming facts and figures, CVD is a devastating, yet often preventable disease, which affects people, families and communities all over the world. Therefore, to reduce the global burden of NCDs and achieve the 25by25 target, it is essential that CVD and its risk factors are addressed.

Agenda 2030 and the Sustainable Development Goals

Agenda 2030 for Sustainable Development: People, Planet and Prosperity

In September 2015, world leaders convened at the United Nations to formally adopt the 2030 Agenda for Sustainable Development; an ambitious global framework to end extreme poverty, eliminate inequality and injustice, improve health outcomes and conserve our planet over the next fifteen years.

Also known as the Sustainable Development Goals (SDGs), the 2030 Agenda succeeds the Millennium Development Goals, which ran from 2000-2015, and comprises 17 major goals supported by 169 targets. Thanks to years of extensive advocacy, health features prominently within the SDGs, as Goal 3 of the Agenda: ‘Ensure healthy lives and promote wellbeing for all at all ages’.

Cardiovascular Disease and Agenda 2030

For the first time in history, non-communicable diseases (NCDs), including cardiovascular disease (CVD), are specifically included in the Agenda as a major development priority. This means that each of the 193 country signatories of the document have committed resources, expertise and collaborative efforts to prevent and control heart disease and other NCDs. Never before have governments been so strongly compelled to act on the global CVD epidemic.

There are three sections of the 2030 Agenda in which NCDs (including CVD) are mentioned explicitly:

  • Introduction: “We are committed to the prevention and treatment of non-communicable diseases, including behavioural, developmental and neurological disorders, which constitute a major challenge for sustainable development.”
  • Target 3.4: “By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.”
  • Target 3.b: “Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries.”

While the inclusion of CVD and NCDs in Agenda 2030 is a landmark achievement, our work is far from over. Now, more than ever, governments need to be encouraged and assisted to achieve the new target of reducing NCDs by one third by 2030. A key way to meet this goal is to continue working towards the World Heart Federation’s target of reducing CVD by 25% by 2025, as CVD continues to cause the highest proportion of non-communicable deaths across the world.

Progress towards 25by25

At the United Nations High-level Meeting on NCDs in 2018 (HLM 2018), WHO Member States will review their progress on NCDs, both nationally and globally, and towards the 4 time-bound commitments set in 2014.

Given the scale of the global NCD epidemic, progress so far has been inadequate, and urgent action is needed. It is now time to increase the pace in terms of advocacy and campaigning so that countries are compelled to act.

Discover our CVD Advocacy Toolkit ‘The Road to 2018’

Download the toolkit

WHF9421_Advocacy_toolkit__PDF-4.pdf (848.49 kB)

Read more about the '25 by 25' campaign

Download the infographic
(1.40 MB)